USP Joins in the Efforts to Stop Illegal Online Drug Sales - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

USP Joins in the Efforts to Stop Illegal Online Drug Sales


As part of a continuing mission to improve global health, the US Pharmacopeial Convention (USP) has joined with the Alliance for Safe Online Pharmacies (ASOP) to combat the threat posed by the illegal online sale of medicines.

Libby Baney, executive director of ASOP, emphasized that effectively confronting illegal online drug sellers requires collaboration by diverse stakeholders to protect patients worldwide.

Baney noted that according to the National Association of Boards of Pharmacy, at any one time there are approximately 40,000-50,000 active online drug sellers; nearly 97% do not comply with applicable laws and pharmacy practice standards, putting patients at risk. Ronald T. Piervincenzi, chief executive officer of USP, added that studies by the World Health Organization indicate that half of the drugs sold on some Internet sites are counterfeit.

Source: US Pharmacopeial Convention

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here